Changes of CD_4~+CD_(25)~+CD_(127)-regulatory T cells level and clinical significance in the peripheral blood of patients with lung cancer
Guangbo Zhang
Abstract
Guangbo Zhang
Abstract
Objective To detect the levels of CD+4CD+25CD127-regulatory T(CD+4CD+25CD127-Treg) cells and the other related immunocyte subsets in the peripheral blood and plasma iterleukin-10(IL-10),interferon-γ(IFN-γ) levels in patients with lung cancer,and to evaluate the dysfunction of cell immunity and its clinical significance.Methods The levels of CD+4CD+25CD127-Treg cells and the other related immunocyte subsets in the peripheral blood were detected by flow cytometry(FCM) method,and plasma IL-10 and IFN-γ levels were determined by enzyme linked immunosorbent assay(ELISA) kits in 45 patients with primary lung cancer,14 patients with benign lung disease and 20 healthy volunteers.Results The levels of CD+4CD+25CD127-Treg cells and CD+4CD28-T cells in the peripheral blood of patients with lung cancer were significantly higher than those of patients with benign lung disease and healthy volunteers respectively.The levels of CD+4,CD+8CD+28-T cells,CD+56 NK cells and ratio of CD+4/CD+8 in the peripheral blood of patients with lung cancer were significantly lower than those in other groups.Plasma IL-10 level in patients with lung cancer was significantly higher than that in other groups.Plasma IFN-γ level in patients with lung cancer was significantly lower than that in other groups.The level of CD+4CD+25CD127-Treg cells in the peripheral blood was positively correlated with plasma IL-10 level and negatively correlated with plasma IFN-γ level in patients with lung cancer.The levels of CD+8CD+28,CD+56 NK and CD+4CD+25CD127-Treg cells,plasma IL-10 and IFN-γ levels were correlated with clinical stage.Conclusion The levels of CD+4CD+25CD127-Treg cells in the peripheral blood might play an important role in the development,progression of lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To detect the levels of CD+4CD+25CD127-regulatory T(CD+4CD+25CD127-Treg) cells and the other related immunocyte subsets in the peripheral blood and plasma iterleukin-10(IL-10),interferon-γ(IFN-γ) levels in patients with lung cancer,and to evaluate the dysfunction of cell immunity and its clinical significance.Methods The levels of CD+4CD+25CD127-Treg cells and the other related immunocyte subsets in the peripheral blood were detected by flow cytometry(FCM) method,and plasma IL-10 and IFN-γ levels were determined by enzyme linked immunosorbent assay(ELISA) kits in 45 patients with primary lung cancer,14 patients with benign lung disease and 20 healthy volunteers.Results The levels of CD+4CD+25CD127-Treg cells and CD+4CD28-T cells in the peripheral blood of patients with lung cancer were significantly higher than those of patients with benign lung disease and healthy volunteers respectively.The levels of CD+4,CD+8CD+28-T cells,CD+56 NK cells and ratio of CD+4/CD+8 in the peripheral blood of patients with lung cancer were significantly lower than those in other groups.Plasma IL-10 level in patients with lung cancer was significantly higher than that in other groups.Plasma IFN-γ level in patients with lung cancer was significantly lower than that in other groups.The level of CD+4CD+25CD127-Treg cells in the peripheral blood was positively correlated with plasma IL-10 level and negatively correlated with plasma IFN-γ level in patients with lung cancer.The levels of CD+8CD+28,CD+56 NK and CD+4CD+25CD127-Treg cells,plasma IL-10 and IFN-γ levels were correlated with clinical stage.Conclusion The levels of CD+4CD+25CD127-Treg cells in the peripheral blood might play an important role in the development,progression of lung cancer.
Key concepts: Lung cancer, Flow cytometry, Lung, Medicine, Immunology, Clinical significance, Peripheral blood, Cancer